Identification and management of familial hypercholesterolaemia: what does it mean to primary care?

被引:48
作者
Qureshi, Nadeem [1 ]
Humphries, Steve E. [2 ]
Seed, Mary [3 ]
Rowlands, Philip [4 ]
Minhas, Rubin
机构
[1] Univ Nottingham, Grad Sch Med, Div Primary Care, Derby DE22 3DT, England
[2] Royal Free & Univ Coll London Med Sch, British Heart Fdn Labs, Ctr Cardiovasc Genet, London, England
[3] Univ London, Lipid Clin, Imperial Coll Healthcare, Dept Cardiol, London WC1E 7HU, England
[4] Briar Bank Studios, Funky Med, Penarth, S Glam, Wales
关键词
family health; familial hypercholesteroaemia; medical genetics; primary health care; ORAL-CONTRACEPTIVES; DIAGNOSIS; DISEASE;
D O I
10.3399/bjgp09X472674
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Familial hypercholesterolaemia is one of the most common dominantly inherited disorders to be identified in primary care, leading to raised serum cholesterol evident from the first year of life. Around 1 in 500 people are affected by this condition, but less than 15% of these are currently attending lipid clinics, suggesting that the vast majority are unrecognised in general practice. The recently released National Institute for Health and Clinical Excellence evidence-based guideline on the identification and management of familial hypercholesterolaemia provides an opportunity to bridge this gap. Primary care has a role in systematic and opportunistic case finding, such as recognising the relevance of a family history of premature coronary heart disease and/or grossly elevated cholesterol. Although affected individuals need specialist care, GPs can reinforce the information provided by specialists and support cascade screening to other affected members of the extended family.
引用
收藏
页码:773 / +
页数:5
相关论文
共 16 条
[1]   Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia [J].
Amundsen, Agot Lia ;
Khoury, Janette ;
Iversen, Per Ole ;
Bergei, Caroline ;
Ose, Leiv ;
Tonstad, Serena ;
Retterstol, Kietil .
ATHEROSCLEROSIS, 2006, 189 (02) :451-457
[2]   Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis [J].
Baillargeon, JP ;
McClish, DK ;
Essah, PA ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07) :3863-3870
[3]  
DeMott K., 2008, Clinical Guidelines and Evidence Review for Familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia
[4]  
Edison R, 2003, AM J HUM GENET, V73, P212
[5]   Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre [J].
Gray, J. ;
Jaiyeola, A. ;
Whiting, M. ;
Modell, M. ;
Wierzbicki, A. S. .
HEART, 2008, 94 (06) :754-758
[6]   Disease knowledge and adherence to treatment in patients with familial hypercholesterolemia [J].
Hollman, Gunilla ;
Olsson, Anders G. ;
Ek, Anna-Christina .
JOURNAL OF CARDIOVASCULAR NURSING, 2006, 21 (02) :103-108
[7]   Oral contraceptives use and the risk of myocardial infarction: a meta-analysis [J].
Khader, YS ;
Rice, J ;
John, L ;
Abueita, O .
CONTRACEPTION, 2003, 68 (01) :11-17
[8]   Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].
LaRosa, JC ;
Grundy, SM ;
Waters, DD ;
Shear, C ;
Barter, P ;
Fruchart, J ;
Gotto, AM ;
Greten, H ;
Kastelein, JJP ;
Shepherd, J ;
Wenger, NK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435
[9]   Census of clinics providing specialist lipid services in the United Kingdom [J].
Marks, D ;
Thorogood, M ;
Farrer, JM ;
Humphries, SE .
JOURNAL OF PUBLIC HEALTH, 2004, 26 (04) :353-354
[10]   A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia [J].
Marks, D ;
Thorogood, M ;
Neil, HAW ;
Humphries, SE .
ATHEROSCLEROSIS, 2003, 168 (01) :1-14